Günter Breithardt
Günter Breithardt (born 19 January 1944 in Haan/Rhineland) is a German physician, cardiologist and emeritus university professor. He is known for his research in the field of rhythmology, especially the diagnosis and pharmacological and non-pharmacological therapy of cardiac arrhythmias and acute cardiac death, in particular the identification of arrhythmia-triggering gene mutations. For 21 years he headed the Medical Clinic and Polyclinic C (Cardiology, Angiology, Intensive Care Medicine) at Münster University Hospital. A number of his academic students hold university management and chief physician positions. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Günter Breithardt', query time: 0.03s
Refine Results
-
1
Transition in Patients with Congenital Heart Disease in Germany: Results of a Nationwide Patient Survey by Paul C. Helm, Paul C. Helm, Harald Kaemmerer, Günter Breithardt, Günter Breithardt, Elisabeth J. Sticker, Roland Keuchen, Rhoia Neidenbach, Gerhard-Paul Diller, Gerhard-Paul Diller, Oktay Tutarel, Ulrike M. M. Bauer, Ulrike M. M. Bauer, Ulrike M. M. Bauer
Published 2017-05-01
Article -
2
Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry). by Holger Reinecke, Günter Breithardt, Christiane Engelbertz, Roland E Schmieder, Manfred Fobker, Hans O Pinnschmidt, Boris Schmitz, Philipp Bruland, Karl Wegscheider, Hermann Pavenstädt, Eva Brand
Published 2016-01-01
Article -
3
Thyroid Dysfunction under Amiodarone in Patients with and without Congenital Heart Disease: Results of a Nationwide Analysis by Alicia Jeanette Fischer, Dominic Enders, Lars Eckardt, Julia Köbe, Kristina Wasmer, Günter Breithardt, Fernando De Torres Alba, Gerrit Kaleschke, Helmut Baumgartner, Gerhard-Paul Diller
Published 2022-04-01
Article -
4
Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial by Anthony P. Carnicelli, Anne S. Hellkamp, Kenneth W. Mahaffey, Daniel E. Singer, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Jonathan P. Piccini, Richard C. Becker, Christopher C. Nessel, Scott D. Berkowitz, Keith A. A. Fox, Robert M. Califf, Manesh R. Patel
Published 2021-10-01
Article -
5
Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial by George C. Leef, Anne S. Hellkamp, Manesh R. Patel, Richard C. Becker, Scott D. Berkowitz, Günter Breithardt, Jonathan L. Halperin, Graeme J. Hankey, Werner Hacke, Christopher C. Nessel, Daniel E. Singer, Keith A.A. Fox, Kenneth W. Mahaffey, Jonathan P. Piccini
Published 2017-11-01
Article -
6
Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial by Gene R. Quinn, Anne S. Hellkamp, Graeme J. Hankey, Richard C. Becker, Scott D. Berkowitz, Günter Breithardt, Maurizio Fava, Keith A. A. Fox, Jonathan L. Halperin, Kenneth W. Mahaffey, Christopher C. Nessel, Manesh R. Patel, Jonathan P. Piccini, Daniel E. Singer
Published 2018-08-01
Article -
7
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF by Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, Manesh R. Patel, Karen S. Pieper, Jonathan L. Halperin, Günter Breithardt, Daniel E. Singer, Graeme J. Hankey, Werner Hacke, Richard C. Becker, Scott D. Berkowitz, Christopher C. Nessel, Kenneth W. Mahaffey, Keith A. A. Fox, Robert M. Califf
Published 2016-03-01
Article -
8
Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF by Francis E. Ugowe, MD, Anne S. Hellkamp, MS, Allen Wang, BS, Richard C. Becker, MD, Scott D. Berkowitz, MD, Günter Breithardt, MD, Keith A.A. Fox, MB ChB, Jonathan L. Halperin, MD, Graeme J. Hankey, MD, Kenneth W. Mahaffey, MD, Christopher C. Nessel, MD, Daniel E. Singer, MD, Manesh R. Patel, MD, Jonathan P. Piccini, MD, MHS, FHRS
Published 2021-06-01
Article